Posted on July 11, 2017 by Laura Fuller
Beloved ‘True Blood’ actor, Nelsan Ellis, passed away this week after complications related to alcoholism and drug addiction. According to a statement released by Ellis’ family – via his longtime manager – the talented actor had been struggling with alcohol and drug misuse for years. They went on to explain that Ellis attempted to… Read On »
Posted on July 10, 2017 by Laura Fuller
Following a controversial request from the FDA, Endo Pharmaceuticals has officially withdrawn one of their potent opioid medications, OPANA ER, from the market. Their decision comes less than a month after the U.S. Food and Drug Administration (FDA) submitted a formal request to stop drug sales, stating that the benefits of the drug no… Read On »
Posted on July 3, 2017 by Laura Fuller
Terri O’Connor has been in the field of addiction treatment for over 25 years, beginning in 1990 when she worked with inner-city youth while pursuing her degree and certification in Addictions Counseling. She held various roles such as Intake Manager and Court Advocacy in the non-profit sector, and was also instrumental in developing substance abuse… Read On »
A Letter From Andrew Rothermel, President & CEO of Origins Behavioral HealthCare Summer is upon us, and we could not be more invigorated by the possibilities for our organization. Since our acquisition by TRT Holdings, Inc., less than two short months ago, it has been our honor to continue to watch Origins’ extraordinary team… Read On »
Posted on June 27, 2017 by Laura Fuller
In order to bring greater awareness to the issue of Post-Traumatic Stress Disorder (PTSD), the United States Senate designated June 27th as National PTSD Awareness Day. Here are a few things you need to know about PTSD and warning signs to look for in your own life or the life of a loved one. PTSD… Read On »
Posted on June 23, 2017 by lfuller@hanleycenter.com
Drew Rothermel, MBA, JD – President and Chief Executive Officer With the opioid crisis now at epidemic proportions, the need to deliver superior substance use disorder treatment has become profoundly important. Desperate for a solution, thousands of struggling patients and their families are finding themselves entangled in the broken system recently highlighted in the New… Read On »
Posted on June 13, 2017 by Laura Fuller
The FDA recently asked Endo Pharmaceuticals to pull its opioid pain medication, Opana ER, from the market citing concerns that the drug’s benefits may no longer outweigh its risks. This is the first time the agency has taken action to stop the sale of an opioid pain medication based on the public health consequences… Read On »
Posted on June 5, 2017 by Kacy
Over a decade’s worth of research recently confirmed that teens who attended high-achieving schools in affluent communities showed a greater vulnerability to drug and alcohol misuse than their peers. This study, released last week in Development and Psychopathology, bolsters previous studies in this area and reaffirms the industry-wide experience of thousands of addiction professionals. “Like… Read On »
Posted on June 2, 2017 by Laura Fuller
In recent news, the state of Ohio filed a suit against five drug companies, accusing them of fueling the opioid crisis by misleading prescribing doctors about the risks of addiction associated with opioid medication. Ohio is the second state to sue opioid manufacturers, with a suit from Mississippi coming earlier this year. “The opioid addiction… Read On »
Posted on May 25, 2017 by Laura Fuller
by Vice President of Clinical Operations, Kerry Coyle, MSW In a shocking news report released yesterday, two staffers were found dead after having overdosed on heroin and fentanyl in an unlicensed Pennsylvania recovery home. The tragic story highlights the critical nature of the opioid epidemic in the United States while drawing attention to systemic concerns about the clinical integrity… Read On »
« Older Entries
